BEIJING: Chinese researchers claim that the first phase of the Kovid vaccine was successful. The results of the research were jointly conducted by several researchers in different labs in China. The first phase of the vaccine was administered to 108 people aged between 18 and 60. Researchers say the vaccine has boosted the immune system in all.
Researchers said that within two weeks, the immune cell ‘T-cell’ had developed, and after 28 days, the antibody for the immune system was formed.
Despite reports that the US and Israel have developed the vaccine, the World Health Organization refused to approve it. US pharmaceutical manufacturer Modena and the University of Oxford in the UK have said on Tuesday that the first phase of drug testing was successful.